Abstract Background Previous studies have used social network variables to improve our understanding of HIV transmission. Similar analytic approaches have not been undertaken for hepatitis C (HCV) or B (HBV), nor used to conduct comparative studies on these pathogens within a single setting. Methods A cross-sectional survey consisting of a questionnaire and blood sample was conducted on injection drug users in Winnipeg between December 2003 and September 2004. Logistic regression analyses were used to correlate respondent and personal network data with HCV, HBV and HIV prevalence. Results At the multivariate level, pathogen prevalence was correlated with both respondent and IDU risk network variables. Pathogen transmission was associated wi...
BACKGROUND: Despite the implementation of harm reduction program, some injecting drug users (IDU) c...
Background: People who inject drugs (PWID) account for some of the most explosive human immunodefici...
Drug injection is an increasingly important risk factor in the transmission of blood-borne pathogens...
We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug...
We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug...
We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug...
Objective: We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using inj...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
Introduction. Injection drug users (IDUs) are at high risk for infection with HIV, hepatitis C virus...
Social network characteristics of people who inject drugs (PWID) have previously been flagged as pot...
Social network characteristics of people who inject drugs (PWID) have previously been flagged as pot...
Background: Despite the implementation of harm reduction program, some injecting drug users (IDU) co...
Abstract Background: Despite the implementation of harm reduction program, some injecting drug user...
Background and aimsCurrent injecting drug users (IDU) in major street drug markets within greater Me...
BACKGROUND: Despite the implementation of harm reduction program, some injecting drug users (IDU) c...
Background: People who inject drugs (PWID) account for some of the most explosive human immunodefici...
Drug injection is an increasingly important risk factor in the transmission of blood-borne pathogens...
We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug...
We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug...
We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug...
Objective: We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using inj...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
Introduction. Injection drug users (IDUs) are at high risk for infection with HIV, hepatitis C virus...
Social network characteristics of people who inject drugs (PWID) have previously been flagged as pot...
Social network characteristics of people who inject drugs (PWID) have previously been flagged as pot...
Background: Despite the implementation of harm reduction program, some injecting drug users (IDU) co...
Abstract Background: Despite the implementation of harm reduction program, some injecting drug user...
Background and aimsCurrent injecting drug users (IDU) in major street drug markets within greater Me...
BACKGROUND: Despite the implementation of harm reduction program, some injecting drug users (IDU) c...
Background: People who inject drugs (PWID) account for some of the most explosive human immunodefici...
Drug injection is an increasingly important risk factor in the transmission of blood-borne pathogens...